Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE IV Study of Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After Percutaneous Aortic Valve Implantation. Multicenter Randomized Clinical Trial

NCT01642134 is registered in ClinicalTrials.gov with Andres Iñiguez Romo, MD, PhD as lead sponsor.

NCT NCT01642134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE IV Study of Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After Percutaneous Aortic Valve Implantation. Multicenter Randomized Clinical Trial
Lead sponsor
Andres Iñiguez Romo, MD, PhD
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2013
Completion date
June 30, 2019
Enrollment
124 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, stroke